Catherine Kim1, Ionut Bebu2, Barbara Braffett2, Patricia A Cleary2, Valerie Arends3, Michael Steffes3, Hunter Wessells4, Trevor Orchard5, Aruna V Sarma6. 1. Departments of Medicine, Obstetrics & Gynecology and Epidemiology, University of Michigan, Ann Arbor, MI, USA. 2. The Biostatistics Center, George Washington University, Rockville, MD, USA. 3. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. 4. Department of Urology, University of Washington, Seattle, WA, USA. 5. Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA. 6. Department of Urology, University of Michigan, Ann Arbor, MI, USA.
Abstract
OBJECTIVE: Low testosterone concentrations have been reported to be associated with increased risk of congestive heart failure, but the mechanisms are unclear. Our objective was to examine the relationship between endogenous testosterone and measures of cardiac mass and function among men with type 1 diabetes. DESIGN: Secondary analysis of a prospective observational study. PARTICIPANTS: Men (n = 508) in the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the observational follow-up of the Diabetes Control and Complications Trial (DCCT). MEASUREMENTS: Testosterone assessed by liquid chromatography mass spectrometry at EDIC year 10 and cardiac magnetic resonance imaging (CMR) measures at EDIC years 14/15. Linear regression models were used to assess the relationship between testosterone, sex hormone binding globulin (SHBG) and left ventricular (LV) mass, volume, ejection fraction and cardiac index before and after adjustment for age, randomization arm, alcohol and cigarette use, macroalbuminuria, haemoglobin A1c, insulin dose, body mass index, lipids, blood pressure, use of antihypertensive medications and microvascular complications. RESULTS: In fully adjusted models, total testosterone concentrations were significantly associated with LV mass (P = 0·014), end-diastolic volume (P = 0·002), end-systolic volume (P = 0·012) and stroke volume (P = 0·022), but not measures of LV function after adjustment for cardiac risk factors. Bioavailable testosterone was associated with LV mass, but not volume or function, while SHBG was associated with volume, but not mass or function. CONCLUSIONS: Among men with type 1 diabetes, higher total testosterone was associated with higher LV mass and volume, but not with function. The clinical significance of this association remains to be established.
RCT Entities:
OBJECTIVE: Low testosterone concentrations have been reported to be associated with increased risk of congestive heart failure, but the mechanisms are unclear. Our objective was to examine the relationship between endogenous testosterone and measures of cardiac mass and function among men with type 1 diabetes. DESIGN: Secondary analysis of a prospective observational study. PARTICIPANTS: Men (n = 508) in the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the observational follow-up of the Diabetes Control and Complications Trial (DCCT). MEASUREMENTS: Testosterone assessed by liquid chromatography mass spectrometry at EDIC year 10 and cardiac magnetic resonance imaging (CMR) measures at EDIC years 14/15. Linear regression models were used to assess the relationship between testosterone, sex hormone binding globulin (SHBG) and left ventricular (LV) mass, volume, ejection fraction and cardiac index before and after adjustment for age, randomization arm, alcohol and cigarette use, macroalbuminuria, haemoglobin A1c, insulin dose, body mass index, lipids, blood pressure, use of antihypertensive medications and microvascular complications. RESULTS: In fully adjusted models, total testosterone concentrations were significantly associated with LV mass (P = 0·014), end-diastolic volume (P = 0·002), end-systolic volume (P = 0·012) and stroke volume (P = 0·022), but not measures of LV function after adjustment for cardiac risk factors. Bioavailable testosterone was associated with LV mass, but not volume or function, while SHBG was associated with volume, but not mass or function. CONCLUSIONS: Among men with type 1 diabetes, higher total testosterone was associated with higher LV mass and volume, but not with function. The clinical significance of this association remains to be established.
Authors: Evrim B Turkbey; Jye-Yu C Backlund; Saul Genuth; Aditya Jain; Cuilian Miao; Patricia A Cleary; John M Lachin; David M Nathan; Rob J van der Geest; Elsayed Z Soliman; Chia-Ying Liu; João A C Lima; David A Bluemke Journal: Circulation Date: 2011-09-26 Impact factor: 29.690
Authors: J B Ruige; E R Rietzschel; M L De Buyzere; S Bekaert; P Segers; D De Bacquer; G De Backer; T C Gillebert; J-M Kaufman Journal: Int J Androl Date: 2011-06-22
Authors: Robin Haring; Zhaoyang Teng; Vanessa Xanthakis; Andrea Coviello; Lisa Sullivan; Shalender Bhasin; Joanne M Murabito; Henri Wallaschofski; Ramachandran S Vasan Journal: Clin Endocrinol (Oxf) Date: 2013-04 Impact factor: 3.478
Authors: Andre B Araujo; Gretchen R Esche; Varant Kupelian; Amy B O'Donnell; Thomas G Travison; Rachel E Williams; Richard V Clark; John B McKinlay Journal: J Clin Endocrinol Metab Date: 2007-08-14 Impact factor: 5.958
Authors: Jessica M Scott; E Lichar Dillon; Michael Kinsky; Albert Chamberlain; Susan McCammon; Daniel Jupiter; Maurice Willis; Sandra Hatch; Gwyn Richardson; Christopher Danesi; Kathleen Randolph; William Durham; Traver Wright; Randall Urban; Melinda Sheffield-Moore Journal: BMC Cancer Date: 2019-08-07 Impact factor: 4.430